Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9585971 Recombinant AAV capsid protein

Patent 9585971 was granted and assigned to California Institute of Technology on March, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

California Institute of Technology

0

Current Assignee

California Institute of Technology

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Benjamin E. Deverman0

Paul H. Patterson0

Viviana Gradinaru0

Date of Patent

March 7, 2017

0

Patent Application Number

144850240

Date Filed

September 12, 2014

0

Patent Citations Received

US Patent 12129287 Recombinant adeno associated virus encoding clarin-1 and uses thereof

0

US Patent 12084659 Modulatory polynucleotides

0

US Patent 12091435 Antibody-evading virus vectors

0

US Patent 12104163 Adeno-associated virus vectors for treatment of Rett syndrome

0

US Patent 12116384 Virus vectors for targeting ophthalmic tissues

0

US Patent 12116589 Treatment of amyotrophic lateral sclerosis (ALS)

0

US Patent 12123002 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

0

US Patent 11680275 Self-regulating AAV vectors for safe expression of MeCP2 in rett syndrome

0

...

Patent Primary Examiner

Benjamin P Blumel

0

Patent abstract

Provided herein are methods of selective screening. In addition, various targeting proteins and sequences, as well as methods of their use, are also provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9585971 Recombinant AAV capsid protein

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool